| 注册
首页|期刊导航|癌症(英文版)|Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine,and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin's lymphoma

Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine,and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin's lymphoma

Yuankai Shi Ping Zhou Xiaohong Han Xiaohui He Shengyu Zhou Peng Liu Jianliang Yang

癌症(英文版)2015,Vol.34Issue(11):522-530,9.
癌症(英文版)2015,Vol.34Issue(11):522-530,9.DOI:10.1186/s40880-015-0045-3

Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine,and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin's lymphoma

Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine,and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin's lymphoma

Yuankai Shi 1Ping Zhou 1Xiaohong Han 1Xiaohui He 1Shengyu Zhou 1Peng Liu 1Jianliang Yang1

作者信息

  • 1. Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs,Beijing 100021, P.R.China
  • 折叠

摘要

关键词

Stem cell transplantation/Mobilization/CHOP regimen/Rituximab/Non-Hodgkin's lymphoma

Key words

Stem cell transplantation/Mobilization/CHOP regimen/Rituximab/Non-Hodgkin's lymphoma

引用本文复制引用

Yuankai Shi,Ping Zhou,Xiaohong Han,Xiaohui He,Shengyu Zhou,Peng Liu,Jianliang Yang..Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine,and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin's lymphoma[J].癌症(英文版),2015,34(11):522-530,9.

基金项目

This work was supported in part by Grants from National Science-Technology Support Plan Projects of China (2014BAI09B12),National Major Project for New Drug Innovation of China (2008ZX09312 and 2012ZX09303012),and the Ministry of Education Doctor Foundation of China (20010023018,20050023045,and 200800230019). (2014BAI09B12)

癌症(英文版)

OACSCDCSTPCDSCI

1000-467X

访问量0
|
下载量0
段落导航相关论文